mias. In Podrid PJ, Kowey PR, eds. Cardiac arrhythmia: mechanisms, diagnosis, and management. Williams and Wilkins, Baltimore, Waverly, 1995:181-194. 7 McGrattan PA, Brown JH, Brown OM. Parasympathetic effects on in vivo rat heart can be regulated through an α1 adrenergic receptor. Circ Res,1987,60:465-471.
8 Warner MR, Levy MN. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y. Circ Res,1989,65:1536-1546.
9 Inoue H, Zipes DP. Changes in atrial and ventricular refractoriness and in atrioventricular nodal conduction produced by combinations of vagal and sympathetic stimulation that result in a constant sinus cycle length. Circ Res,1987,60：942-951.
10 Jalife J, Moe GK. Phasic effects of vagal stimulation on pacemaker activity of the isolated sinus node of the young cat. Circ Res,1979,45:595-607.
11 Mazgalev T, Dreifus LS, Michelson EL. A new mechanism for atrioventricular nodal gap-vagal modulation of conduction. Circulation,1989,79:417-430.
12 Tsuji H, Fujiki A, Tani M, et al. Quantitative relationship between atrial refractoriness and the dispersion of refractoriness in atrial vulnerability. PACE,1992,15:403-410.
13 林治湖, 刘少稳. 自主神经在阵发性心房颤动中的作用. 中华心血管病杂志,1996,24:462-463.
14 Meesmann M, Karagueuzian HS, Ino T, et al. The role of enhanced vagal activity on ischemic ventricular tachycardia: pharmacologic basis of inefficiency. Am Heart J,1991,121:1703-1713.
15 Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol,1993,22:72A-84A
上一页 [1] [2] [3]
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文